Loci Orthopaedics Limited
USPTO PatentsView assignee record - 5 granted patents across 2 technology areas, recorded in grant years 2020–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).
The verdict
According to USPTO PatentsView, Loci ranks #48,433 of 49,997 tracked US assignees by granted-patent volume, with 5 patents across 2 technology areas.
- #48,433
- of 49,997 US assignees by volume
- Top 27%
- by Innovation Score (44.0/100)
- 21.4
- avg claims per patent
USPTO PatentsView assignee plate
Corpus R48433 · Foreign Corporation #48,433 · 5 grants
GRANTS-MICRO · BOTTOM-DECILE · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-DENSE · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH
- GRANTS-MICRO 5 grants
- BOTTOM-DECILE #48,433/49,997
- PHOTO-FINISH Liverpool School of…
- CPC-NARROW A61F · 2 areas
- INNOV-PAR 44.0/100
- CLAIMS-DENSE 21.4 claims/avg
- TYPE-FRNCORP Foreign Corp
- SPAN-YRS 2020–2024 · 5y
- BOOK-RICH 9/10 fields
Nearest grant-volume peer: Liverpool School of Tropical Medicine (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Loci’s 44.0 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Loci
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Institute of New… · near
Institute of New… · near
44 score
- Carlisle Constructio… · near
Carlisle Constructio… · near
44 score
- Directa Plus S p A · near
Directa Plus S p A · near
44 score
- Loci Orthopaedics · this assignee
Loci Orthopaedics · this assignee
44 score
- Lumentum Japan · near
Lumentum Japan · near
44 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Loci's Innovation Score is 44.0/100 (top 27% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Loci?
Each dot is one of Loci’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Loci’s own 21.4 claims/patent is ABOVE the 17.6 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Loci's grants concentrate
Loci Orthopaedics Limited is a focused PatentsView assignee: 2 CPC subclasses with 100% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2023 (2 grants) versus a trough of 1 in 2020. By volume, Loci sits between Liverpool School of Tropical Medicine and Los Angeles Biomedical Research Institute.
Loci's three-year grant acceleration
Loci Orthopaedics Limited shows 4 grants in 2022–2024 against only 1 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Loci's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
What this shows Loci holds 5 patents at rank #48,478, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Loci
By rank, the assignees closest to #48,478 in granted patent volume.
- Liverpool School of Tropical Medicine #48,474 · 5 patents
- Livescribe Inc. #48,475 · 5 patents
- Living technology (shenzhen) Co., Ltd. #48,476 · 5 patents
- Local Bounti Operating Company LLC #48,477 · 5 patents
- Loftie Inc. #48,479 · 5 patents
- LogicBlox, Inc. #48,480 · 5 patents
- Lombardini S.r.L #48,481 · 5 patents
- Los Angeles Biomedical Research Institute #48,482 · 5 patents
Leaders in A61F (Filters Implantable Into Blood Vessels)
Other assignees with the most granted patents in Loci's primary technology class.
- The Procter & Gamble Company 1,426 in class
- Boston Scientific Scimed, Inc. 1,101 in class
- Edwards Lifesciences Corporation 1,101 in class
- DePuy Synthes Products, Inc. 851 in class
- Globus Medical, Inc. 752 in class
- Cook Medical Technologies LLC 700 in class
- Smith & Nephew, Inc. 541 in class
- Covidien LP 528 in class
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for Loci, neither rank-band nor same-CPC leaders (those blocks stay above). In A61F (Filters Implantable Into Blood Vessels), Loci ranks #1,191 of 3,082 assignees by patent count in that subclass.
Similar innovation score
Nearest assignees by Innovation Score (44 here).
Loci's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
44 Top 27% higher than 73% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2020 | 1 | 20.0% |
| 2023 | 2 | 40.0% |
| 2024 | 2 | 40.0% |
Which technologies does Loci Orthopaedics Limited patent most?
Top 2 of 2 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Loci Orthopaedics Limited's patent record in context - here's where to go next.
- Loci Orthopaedics Limited's lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 100% of its portfolio - see every assignee active in that class. Explore A61F
- Ranked #48,433 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Loci Orthopaedics Limited against Liverpool School of Tropical Medicine, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 44.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.